Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 1.05
(-1.88%)
EUR 1.05
(-1.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 51.13 Million EUR | -5.11% |
| 2022 | 53.89 Million EUR | 1.63% |
| 2021 | 53.02 Million EUR | 15.79% |
| 2020 | 45.79 Million EUR | 13.68% |
| 2019 | 40.28 Million EUR | 9.35% |
| 2018 | 36.83 Million EUR | -8.09% |
| 2017 | 40.08 Million EUR | -19.81% |
| 2016 | 49.98 Million EUR | 7.66% |
| 2015 | 46.42 Million EUR | 17.84% |
| 2014 | 39.39 Million EUR | 67.16% |
| 2013 | 23.56 Million EUR | 1.77% |
| 2012 | 23.15 Million EUR | 9.9% |
| 2011 | 21.07 Million EUR | -2.59% |
| 2010 | 21.63 Million EUR | 8.53% |
| 2009 | 19.93 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 49.61 Million EUR | 0.0% |
| 2023 Q2 | 50.49 Million EUR | 0.0% |
| 2023 Q1 | 50.49 Million EUR | -6.3% |
| 2023 Q4 | 51.13 Million EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 51.13 Million EUR | -5.11% |
| 2022 Q3 | 53.89 Million EUR | -1.18% |
| 2022 Q2 | 54.53 Million EUR | 0.0% |
| 2022 Q1 | 54.53 Million EUR | 2.85% |
| 2022 FY | 53.89 Million EUR | 1.63% |
| 2022 Q4 | 53.89 Million EUR | 0.0% |
| 2021 Q3 | 53.02 Million EUR | 2.23% |
| 2021 Q2 | 51.87 Million EUR | 0.0% |
| 2021 FY | 53.02 Million EUR | 15.79% |
| 2021 Q4 | 53.02 Million EUR | 0.0% |
| 2021 Q1 | 51.87 Million EUR | 13.27% |
| 2020 Q3 | 45.79 Million EUR | 5.41% |
| 2020 Q1 | 43.44 Million EUR | 7.85% |
| 2020 FY | 45.79 Million EUR | 13.68% |
| 2020 Q2 | 43.44 Million EUR | 0.0% |
| 2020 Q4 | 45.79 Million EUR | 0.0% |
| 2019 FY | 40.28 Million EUR | 9.35% |
| 2019 Q4 | 40.28 Million EUR | 0.0% |
| 2019 Q1 | 37.47 Million EUR | 1.74% |
| 2019 Q2 | 37.47 Million EUR | 0.0% |
| 2019 Q3 | 40.28 Million EUR | 7.48% |
| 2018 Q1 | 38.26 Million EUR | -4.54% |
| 2018 Q2 | 38.26 Million EUR | 0.0% |
| 2018 FY | 36.83 Million EUR | -8.09% |
| 2018 Q4 | 36.83 Million EUR | 0.0% |
| 2018 Q3 | 36.83 Million EUR | -3.72% |
| 2017 FY | 40.08 Million EUR | -19.81% |
| 2017 Q4 | 40.08 Million EUR | 0.0% |
| 2017 Q3 | 40.08 Million EUR | -4.39% |
| 2017 Q2 | 41.92 Million EUR | 0.0% |
| 2017 Q1 | 41.92 Million EUR | -16.13% |
| 2016 Q4 | 49.98 Million EUR | 0.0% |
| 2016 Q2 | 45.84 Million EUR | 0.0% |
| 2016 Q3 | 49.98 Million EUR | 9.02% |
| 2016 Q1 | 45.84 Million EUR | -1.24% |
| 2016 FY | 49.98 Million EUR | 7.66% |
| 2015 Q4 | 46.42 Million EUR | -0.69% |
| 2015 FY | 46.42 Million EUR | 17.84% |
| 2015 Q3 | 46.74 Million EUR | 14.77% |
| 2015 Q2 | 40.72 Million EUR | 0.0% |
| 2015 Q1 | 40.72 Million EUR | 3.39% |
| 2014 FY | 39.39 Million EUR | 67.16% |
| 2014 Q4 | 39.39 Million EUR | 0.0% |
| 2014 Q3 | 39.39 Million EUR | 90.35% |
| 2014 Q2 | 20.69 Million EUR | 0.0% |
| 2014 Q1 | 20.69 Million EUR | -12.18% |
| 2013 Q2 | 20.83 Million EUR | 0.0% |
| 2013 FY | 23.56 Million EUR | 1.77% |
| 2013 Q3 | 23.56 Million EUR | 13.14% |
| 2013 Q4 | 23.56 Million EUR | 0.0% |
| 2013 Q1 | 20.83 Million EUR | -10.05% |
| 2012 FY | 23.15 Million EUR | 9.9% |
| 2012 Q2 | 25.37 Million EUR | 0.0% |
| 2012 Q4 | 23.15 Million EUR | 0.0% |
| 2011 Q2 | 17.36 Million EUR | 0.0% |
| 2011 Q4 | 21.07 Million EUR | 0.0% |
| 2011 FY | 21.07 Million EUR | -2.59% |
| 2010 FY | 21.63 Million EUR | 8.53% |
| 2010 Q4 | 21.63 Million EUR | 0.0% |
| 2010 Q2 | 18.74 Million EUR | 0.0% |
| 2009 Q4 | 19.93 Million EUR | 0.0% |
| 2009 Q2 | 23.72 Million EUR | 0.0% |
| 2009 FY | 19.93 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Affluent Medical SA | 56.62 Million EUR | 9.687% |
| Bluelinea Société Anonyme | 13.16 Million EUR | -288.447% |
| Carmat SA | 53.06 Million EUR | 3.639% |
| Euromedis Groupe | 46.25 Million EUR | -10.549% |
| Eurobio Scientific Société anonyme | 315.81 Million EUR | 83.808% |
| Ikonisys S.A. | 20.85 Million EUR | -145.236% |
| Implanet S.A. | 10.63 Million EUR | -380.756% |
| Median Technologies SA | 35.81 Million EUR | -42.796% |
| SpineGuard SA | 11.03 Million EUR | -363.402% |
| Theraclion SA | 18.66 Million EUR | -173.999% |
| Euroapi S.A. | 1.61 Billion EUR | 96.828% |
| Guerbet SA | 1.02 Billion EUR | 95.012% |
| Ion Beam Applications SA | 597.52 Million EUR | 91.442% |
| Koninklijke Philips N.V. | 29.7 Billion EUR | 99.828% |
| Sequana Medical NV | 10.1 Million EUR | -406.265% |